Optomed Oyj Future Growth
Future criteria checks 2/6
Optomed Oyj is forecast to grow earnings and revenue by 62.3% and 22.4% per annum respectively. EPS is expected to grow by 62.8% per annum. Return on equity is forecast to be -18.5% in 3 years.
Key information
62.3%
Earnings growth rate
62.8%
EPS growth rate
| Medical Equipment earnings growth | 24.3% |
| Revenue growth rate | 22.4% |
| Future return on equity | -18.5% |
| Analyst coverage | Low |
| Last updated | 02 May 2024 |
Recent future growth updates
Recent updates
Market Might Still Lack Some Conviction On Optomed Oyj (HEL:OPTOMED) Even After 25% Share Price Boost
Mar 22
Earnings Update: Optomed Oyj (HEL:OPTOMED) Just Reported And Analysts Are Trimming Their Forecasts
Feb 18Market Cool On Optomed Oyj's (HEL:OPTOMED) Revenues
Dec 21Is Optomed Oyj (HEL:OPTOMED) Using Debt In A Risky Way?
Nov 15Earnings Update: Optomed Oyj (HEL:OPTOMED) Just Reported And Analysts Are Trimming Their Forecasts
Aug 09Investors Continue Waiting On Sidelines For Optomed Oyj (HEL:OPTOMED)
Jun 01Does Optomed Oyj (HEL:OPTOMED) Have A Healthy Balance Sheet?
Oct 27Is Optomed Oyj (HEL:OPTOMED) A Risky Investment?
Apr 23Optomed Oyj (HEL:OPTOMED) Has Debt But No Earnings; Should You Worry?
Aug 05The Optomed Oyj (HEL:OPTOMED) Share Price Has Gained 14% And Shareholders Are Hoping For More
Feb 16Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 30 | 0 | 0 | 2 | 1 |
| 12/31/2025 | 25 | -3 | -3 | -1 | 3 |
| 12/31/2024 | 17 | -4 | -5 | -3 | 2 |
| 12/31/2023 | 15 | -4 | -3 | -1 | N/A |
| 9/30/2023 | 15 | -4 | -3 | 0 | N/A |
| 6/30/2023 | 15 | -5 | -4 | -2 | N/A |
| 3/31/2023 | 15 | -5 | -5 | -2 | N/A |
| 12/31/2022 | 15 | -5 | -5 | -2 | N/A |
| 9/30/2022 | 14 | -6 | -6 | -3 | N/A |
| 6/30/2022 | 14 | -5 | -6 | -3 | N/A |
| 3/31/2022 | 14 | -5 | -6 | -3 | N/A |
| 12/31/2021 | 15 | -4 | -6 | -3 | N/A |
| 9/30/2021 | 15 | -3 | -4 | -2 | N/A |
| 6/30/2021 | 15 | -2 | -4 | -2 | N/A |
| 3/31/2021 | 14 | -3 | -2 | 0 | N/A |
| 12/31/2020 | 13 | -3 | -5 | -3 | N/A |
| 9/30/2020 | 13 | -3 | -3 | -1 | N/A |
| 6/30/2020 | 13 | -4 | -3 | -1 | N/A |
| 3/31/2020 | 15 | -4 | -4 | -2 | N/A |
| 12/31/2019 | 15 | -3 | -1 | 0 | N/A |
| 9/30/2019 | 16 | -2 | -2 | 0 | N/A |
| 12/31/2018 | 14 | -1 | -2 | 0 | N/A |
| 12/31/2017 | 7 | -3 | -3 | -1 | N/A |
| 12/31/2016 | 7 | -3 | N/A | -1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: OPTOMED is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: OPTOMED is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: OPTOMED is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: OPTOMED's revenue (22.4% per year) is forecast to grow faster than the Finnish market (2.6% per year).
High Growth Revenue: OPTOMED's revenue (22.4% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: OPTOMED is forecast to be unprofitable in 3 years.